Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 84.74 |
| Open | 84.25 |
| Bid | 84.15 x 700 |
| Ask | 84.22 x 700 |
| Day's Range | 84.01 - 84.93 |
| 52 Week Range | 62.07 - 87.87 |
| Volume | |
| Avg. Volume | 6,550,909 |
| Market Cap | 104.791B |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 102.65 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.08 (3.66%) |
| Ex-Dividend Date | Sept 13, 2024 |
| 1y Target Est | N/A |
- Zacks
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its investigational medicine, lenacapavir, for HIV Prevention.
- Zacks
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
- Zacks
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $83.94, denoting a +0.12% change from the preceding trading day.
© 2024 Yahoo. All rights reserved.